|
Revolution Medicines Inc (NASDAQ: RVMD) |
|
|
|
| |
Revolution Medicines Inc 's Competition Data
(in $ except Marketcap in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
MARKET CAP |
REV./EMPLOYEE |
INC./EMPLOYEE |
| Revolution Medicines Inc |
RVMD |
6,628 |
146,089 |
-2,970,757 |
| Pfizer Inc |
PFE |
130,359 |
709,807 |
89,909 |
| Merck and Co Inc |
MRK |
192,193 |
887,806 |
242,375 |
| Novartis Ag |
NVS |
229,262 |
428,073 |
136,275 |
| Bristol myers Squibb Company |
BMY |
95,682 |
1,396,950 |
159,443 |
| Scinai Immunotherapeutics Ltd |
SCNI |
4,547 |
- |
270,833 |
| Astrazeneca Plc |
AZN |
107,481 |
551,276 |
71,733 |
| Gilead Sciences Inc |
GILD |
129,048 |
1,596,389 |
331,389 |
| Mesoblast Ltd |
MESO |
11,570 |
29,363 |
-437,592 |
| Immunitybio inc |
IBRX |
2,423 |
154,564 |
-2,025,649 |
| Sorrento Therapeutics Inc |
SRNEQ |
18 |
1,700,800 |
-10,817,267 |
| Amgen Inc |
AMGN |
147,375 |
1,392,667 |
170,417 |
| Iovance Biotherapeutics inc |
IOVA |
536 |
1,575,400 |
-2,780,474 |
| Exelixis Inc |
EXEL |
13,083 |
4,061,700 |
2,617,719 |
| Autolus Therapeutics Plc |
AUTL |
354 |
826 |
-1,184,741 |
| Orchard Therapeutics Plc |
ORTX |
3,814 |
218,390 |
-729,210 |
| Allogene Therapeutics Inc |
ALLO |
239 |
1,079 |
-1,101,847 |
| Biocryst Pharmaceuticals Inc |
BCRX |
2,204 |
2,555,761 |
-271,421 |
| Seagen Inc |
SGEN |
43,034 |
1,916,959 |
-625,188 |
| Gamida Cell Ltd |
GMDA |
6 |
- |
809,949 |
| Tevogen Bio Holdings Inc |
TVGN |
166 |
- |
-570,761 |
| Biogen Inc |
BIIB |
18,411 |
1,296,750 |
195,416 |
| Compass Therapeutics Inc |
CMPX |
290 |
- |
-520,953 |
| Vir Biotechnology Inc |
VIR |
632 |
103,786 |
-2,873,876 |
| Tscan Therapeutics Inc |
TCRX |
161 |
90,224 |
-2,683,347 |
| Halozyme Therapeutics Inc |
HALO |
6,588 |
360,115 |
161,197 |
| Fate Therapeutics Inc |
FATE |
127 |
60,614 |
-799,450 |
| Coherus Biosciences inc |
CHRS |
88 |
213,279 |
-141,401 |
| Alector Inc |
ALEC |
121 |
362,045 |
-505,906 |
| Zura Bio Limited |
ZURA |
103 |
- |
- |
| Innate Pharma Sa |
IPHA |
177 |
385,687 |
-47,365 |
| Fusion Pharmaceuticals Inc |
FUSN |
1,805 |
33,481 |
-3,862,074 |
| In8bio Inc |
INAB |
11 |
- |
-1,523,611 |
| Sutro Biopharma Inc |
STRO |
76 |
330,517 |
-1,219,980 |
| Enzon Pharmaceuticals inc |
ENZN |
7 |
- |
- |
| Cel sci Corporation |
CVM |
15 |
- |
-909,467 |
| Cardiol Therapeutics inc |
CRDL |
72 |
- |
-1,077,314 |
| Ambrx Biopharma Inc |
AMAM |
1,743 |
209,805 |
-3,271,049 |
| Cullinan Therapeutics Inc |
CGEM |
442 |
- |
-1,610,234 |
| Apogee Therapeutics Inc |
APGE |
2,364 |
- |
-20,539,100 |
| Black Diamond Therapeutics Inc |
BDTX |
112 |
- |
25,203 |
| Arcellx Inc |
ACLX |
3,248 |
3,491,318 |
-7,382,727 |
| Argenx se |
ARGX |
30,760 |
1,222,876 |
-1,013,706 |
| Iteos Therapeutics Inc |
ITOS |
338 |
2,893,178 |
-833,191 |
| Tradeup Acquisition Corp |
ESLA |
34 |
- |
- |
| Lexeo Therapeutics Inc |
LXEO |
108 |
- |
-3,643,567 |
| Molecular Partners Ag |
MOLN |
126 |
61,200 |
-538,991 |
| Dyadic International Inc |
DYAI |
32 |
102,806 |
-170,858 |
| Peak Bio Inc |
PKBO |
1 |
- |
- |
| Turnstone Biologics Corp |
TSBX |
8 |
- |
-1,260,280 |
| Armata Pharmaceuticals Inc |
ARMP |
29 |
566,125 |
-2,364,500 |
| Mural Oncology Plc |
MURA |
45 |
- |
-3,894,364 |
| Jasper Therapeutics Inc |
JSPR |
74 |
- |
-3,751,524 |
| Sab Biotherapeutics Inc |
SABS |
17 |
931,987 |
-544,069 |
| Aligos Therapeutics Inc |
ALGS |
51 |
327,000 |
-5,326,000 |
| Calidi Biotherapeutics Inc |
CLDI |
3 |
- |
-2,220,900 |
| Atara Biotherapeutics Inc |
ATRA |
51 |
1,699,281 |
-558,190 |
| Aceragen Inc |
ACGN |
3 |
- |
-586,414 |
| Mosaic Immunoengineering Inc |
PTSC |
0 |
- |
- |
| Biomx Inc |
PHGE |
3 |
- |
- |
| Aptose Biosciences Inc |
APTO |
4 |
- |
-1,641,000 |
| Ladrx Corporation |
LADX |
1 |
- |
- |
| Phoenix Biotech Acquisition Corp |
PBAXU |
0 |
- |
- |
| Genenta Science S p a |
GNTA |
0 |
- |
-332,733 |
| Springworks Therapeutics Inc |
SWTX |
0 |
- |
-4,143,119 |
| AVERAGE |
SUBTOTAL |
1,188,303 |
777,832 |
129,351 |
|
|
